



 1400   —   4   27
Insulinoma: A Rare Cause of Hypoglycemia in 
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 Patient: Male, 11
 Final Diagnosis: Insulinoma
 Symptoms: Dizziness • psychological issues
 Medication: —
 Clinical Procedure: —
 Specialty: Endocrinology and Metabolic
 Objective: Rare disease
 Background: Insulinomas are pancreatic neuroendocrine tumors that cause non-ketotic hypoglycemia due to hyperinsulinism; 
they are extremely rare, especially in children.
 Case Report: We present a case of a sporadic insulinoma in an 11-year-old boy who had episodes of self-limited drowsiness 
and behavior changes over a 3-month period, thought to be caused by psychological issues. Non-ketotic 
hypoglycemia was confirmed at our center. A fasting blood test found inappropriately elevated insulin levels 
during hypoglycemia, undetectable b-hydroxybutyrate, and increased C-peptide levels in line with insulin 
levels. Anti-insulin antibodies were negative and antidiabetic drugs untraceable. The glucagon-stimulation 
test was positive. Growth hormone, adrenocorticotropin hormone, and phosphorus and calcium metabolism 
were normal. Dual-phase computed tomography detected a lesion compatible with an insulinoma. Endoscopic 
ultrasound showed a homogenous lesion at the junction of the body and tail of the pancreas. Histologic anal-
ysis of a fine-needle aspiration biopsy was compatible with neuroendocrine neoplasia. Preoperatively, a frac-
tional diet avoiding fast-absorbing carbohydrates maintained normal glucose blood levels. Enucleation was not 
possible, so the lesion was resected along with portions of the body and tail of the pancreas. The well-differ-
entiated tumor measured 15×13 mm. Postoperative blood glucose levels were correct, allowing a normal diet.
 Conclusions: In children with unspecific symptoms compatible with hypoglycemia, blood glucose must be evaluated to 
confirm low blood glucose levels. Determining blood ketone levels is important for the differential diagnosis. 
The diagnostic approach to pediatric insulinoma represents a challenge for multidisciplinary teamwork.
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Background
Insulinomas are extremely rare, with an estimated incidence 
of 1 to 4 cases per million persons per year [1–3]; most insu-
linomas are diagnosed in adults [4].
Insulinomas are insulin-producing neuroendocrine pancre-
atic tumors that cause non-ketotic hypoglycemia due to en-
dogenous hyperinsulinism [5]. The initial diagnosis is based 
on Whipple’s triad: symptoms compatible with hypoglycemia, 
low blood glucose levels measured at the time of symptoms, 
and improvement in symptoms after carbohydrates adminis-
tration [6]; the diagnosis is confirmed by the demonstration of 
inadequately high serum insulin levels during hypoglycemia [7].
Insulinomas are usually benign, isolated lesions, but malignant 
insulinomas have been reported in children [8]. About 10% of 
insulinomas are associated with multiple endocrine neoplasia 
type 1 (MEN-1) [1,2,9]. MEN-1 is an autosomal dominant syn-
drome in which tumors develop in the parathyroid, anterior 
pituitary, and pancreas. In more than 85% of patients, para-
thyroid tumors are the first manifestation, resulting in prima-
ry hyperparathyroidism [10].
Case Report
An 11-year-old white boy was admitted to our pediatric emer-
gency room for an episode of fainting lasting a few seconds. 
Blood tests revealed hypoglycemia (42 mg/dL); intravenous 
infusion 10% glucose normalized his blood sugar levels and 
his symptoms resolved.
His family explained that over the previous 3 months, coincid-
ing with his parents’ recent separation, he had had self-limit-
ing episodes of dizziness, sometimes needing to lie down for 
a few seconds, almost always in the morning before going to 
school. During the last few weeks, he also showed a change of 
character, with moments of agitation alternating with drows-
iness. His parents thought that the symptoms were psycho-
logical and related to his family situation, and the boy had an 
upcoming appointment at a mental health center.
Blood glucose returned to normal after intravenous glucose 
infusion. The boy was discharged home on a Saturday eve-
ning and was scheduled for a follow-up visit at our pediatric 
Endocrinology Department 2 days later. He was given a glu-
cometer to check his blood sugar if symptoms reappeared.
He returned to the Emergency Department 48 h after dis-
charge, before his scheduled appointment, for a self-limited 
episode of diplopia with capillary glycemia 45 mg/dL measured 
at home. On arrival at the hospital, the boy was asymptomatic, 
but capillary glycemia was 44 mg/dL without ketonemia. His hy-
poglycemia was treated, and he was admitted for observation.
A fasting glucose test found hypoglycemia (21 mg/dL) within 
2 h in the presence of inappropriately elevated insulin concen-
trations (10.6 µU/mL) and C-peptide levels (1.77 ng/mL). Tests 
for anti-insulin antibodies and oral antidiabetic drugs were 
negative. b-hydroxybutyrate was undetectable in the blood. 
Cortisol, ACTH, GH, and phosphorus and calcium metabolism 
were normal; together with the absence of a family history, 
these findings made the diagnosis of MEN1 highly unlikely. 
The glucagon test was positive: glycemia increased from 
45 mg/dL to 104 mg/dL, pointing to endogenous hyperinsulinism.
Findings of an abdominal ultrasound were normal. Dual-phase 
computed tomography (CT) within 24 h of admission showed 
an isolated enhancing lesion measuring 11 mm in diameter 
in the junction of the body and tail of the pancreas, compati-
ble with insulinoma (Figure 1).
Endoscopic ultrasound showed a homogeneous isoechoic lesion 
measuring 11 mm x 13 mm in the junction of the body and 
tail of the pancreas that lacked the “salt-and-pepper” pattern 
characteristic of normal pancreatic tissue. Histologic exami-
nation of the fine-needle aspiration (FNA) biopsy specimen 
found large cytoplasmic cells with large, eccentric nuclei con-
taining granular chromatin, findings compatible with neuro-
endocrine neoplasia. Immunohistochemistry was positive for 
synaptophysin and chromogranin, and the estimated prolifer-
ation index was 5% (Figure 2).
The Surgical Committee opted for laparoscopic partial 
pancreatectomy.
Figure 1.  Dual-phase abdominal CT. Enhancing lesion measuring 
10 mm in diameter in the junction of the body and tail 
of the pancreas.
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Preoperatively, our patient had a severe tendency to hypo-
glycemia; his blood glucose levels dropped below 50 mg/dL 
after ingesting fast-absorbing carbohydrates or during fast-
ing longer than 3 hours. Blood glucose levels normalized with 
adherence to a diet consisting of frequent meals with small 
portions and avoiding fast-absorbing carbohydrates. The tu-
mor location precluded enucleation, so the tumor was resect-
ed with part of the body and tail of the pancreas under in-
traoperative ultrasound guidance. No complications occurred 
during the procedure.
A histologic study showed a well-differentiated pancreatic neu-
roendocrine tumor measuring 15×13 mm (Figure 3) made up 
of large trabeculae and solid nests of cells larger than the islet 
cells in the rest of the pancreas; the tumor cells had round 
central nuclei with thick chromatin and prominent nucleoli. 
No necrosis or mitotic figures were seen. Immunohistochemistry 
showed diffuse and intense expression of synaptophysin and 
heterogeneous expression of chromogranin (Figure 4).
After surgery, blood glucose levels remained within the nor-
mal range, allowing the patient to have a normal diet. He pre-
sented no further symptoms of hypoglycemia, and subsequent 
follow-ups were normal. He has not developed carbohydrate 
intolerance to date.
Discussion
This case illustrates how insulinomas may be initially mistaken 
for a psychological or neurological disorder [1,9,11]. Unspecific 
symptoms such as dizziness, drowsiness, or behavioral changes 
in children – especially in the mornings, after fasting through 
the night – might be due to hypoglycemia [11–13], and it is 
important to check Whipple’s triad to rule out an insulinoma.
In the differential diagnosis of hypoglycemia in children, 
it is fundamental to determine whether ketonemia is present. 
Ketonemia is present in hypoglycemias caused by a wide range 
of conditions, such as substrate deficiency, deficiency of coun-
terregulatory hormones, abnormal liver glycogen metabolism, 
or ketotic hypoglycemia [9]. Ketonemia is not present in fatty-
acid metabolism disorders (in which blood levels of fatty acids 
are elevated) or in hyperinsulinemic hypoglycemia. In hyperin-
sulinism, C-peptide levels in line with elevated insulin levels, 
together with negative screening for antidiabetic drugs, help 
rule out exogenous causes and direct the diagnosis toward 
an insulinoma or congenital hyperinsulinism [9]. Given that 
congenital hyperinsulinism usually manifests in the neonatal 
Figure 2.  Fine-needle aspiration biopsy. Large cytoplasmic cells 
with large nuclei, positive for chromogranin (brown) in 
immunohistochemistry.
Figure 4.  Microscopic image showing the synaptophysin-positive 
cells in brown. A well-delimited, non-encapsulated 
lesion resembling a giant Langerhans islet can be 
identified. In the rest of the pancreatic parenchyma, 
normal-appearing Langerhans islets can be observed.
Figure 3.  Surgical specimen. The insulinoma, a round lesion 
measuring 15×13 mm with free margins, is located 
in the center of a triangular fragment of resected 
pancreas measuring 40×32×16 mm.
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period [3], we reasoned that the endogenous hyperinsulinism 
in this 11-year-old boy was most likely due to an insulinoma.
Abdominal CT located the lesion, endoscopic ultrasound con-
firmed its presence and enabled its biopsy, and histologic anal-
ysis confirmed that it was a neuroendocrine tumor.
Although some authors recommend MRI as the first-line 
imaging test because it does not use ionizing radiation and has 
a higher sensitivity than CT [9,14,15], the sensitivity of dual-
phase CT is also high (85–100%) [16,17]. In some reported cas-
es, abdominal ultrasonography identified an insulinoma [3,12], 
but not in our case. The sensitivity of 18F-DOPA PET/CT is in-
consistent [15,18]. When other techniques fail to demonstrate 
an insulinoma in cases with strong suspicion, intra-arterial cal-
cium stimulation yields good results [19]. Intraoperative ultra-
sound has multiple advantages that optimize treatment [19].
Endoscopic ultrasound combined with FNA is a new strat-
egy for diagnosing pancreatic neuroendocrine tumors. This 
technique is believed to have better sensitivity than CT or 
MRI [20–23], although some authors disagree [15]. It is im-
portant to remember that endoscopic ultrasound is operator-
dependent and that the technique is evolving [15,24]. A small, 
homogenous lesion, as in our case, suggests a benign endo-
crine tumor [20,22]. Furthermore, endoscopic ultrasound can 
guide FNA biopsy, which can confirm the diagnosis of neuro-
endocrine tumors, although additional studies are required to 
grade malignant lesions [22]. Further investigations are need-
ed to establish recommendations on the diagnostic approach 
to pediatric insulinoma.
The standard treatment of insulinoma is surgery, but en-
doscopic-ultrasound-guided ethanol ablation of pancreat-
ic neuroendocrine tumors has proven safe and efficacious in 
adult patients in whom surgery is contraindicated [25–27]. 
We considered ethanol ablation of the lesion in our patient, 
because endoscopic ultrasound was performed and our cen-
ter is experienced in this technique; however, we found no re-
ports of ethanol ablation in children and our patient had no 
contraindications for surgery. In this case, our team opted for 
the classic surgical treatment, although it is not risk free [26]; 
nevertheless, ethanol ablation is a promising management 
strategy that we will consider in the future.
A fractional diet avoiding fast-absorbing carbohydrates was 
sufficient for our patient to maintain normal glucose blood 
levels without having to resort to medications with known 
adverse effects [3] and that are not always efficacious [15].
Conclusions
In children with unspecific symptoms compatible with hypo-
glycemia, blood glucose must be evaluated to confirm the ex-
istence of low blood glucose levels. This simple procedure can 
allow the diagnosis of severe but treatable diseases. After hy-
poglycemia is confirmed, another simple test, determining 
blood ketone levels, is very useful for differential diagnosis.
The diagnostic approach to pediatric insulinoma encompass-
es a wide range of possibilities and represents a challenge for 
multidisciplinary teamwork.
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